Conjunctivitis - Secondary to long term eye therapy with topically applied drugs or solutions Factor
Last reviewed for CCPS 27 September 1999.
Preliminary questions [10004]
10076 there is some evidence that long term eye therapy with topically applied drugs or solutions may be a factor in the development of the condition under consideration.
10067 the veteran has received long term eye therapy with topically applied drugs or solutions at some time.
10068 the veteran has received long term therapy with topically applied drugs or solutions to side and site of the body at some time.
the long term therapy with topically applied drugs or solutions to side and site of the body was given for an illness or injury which is identifiable.22047 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and VEA service for conjunctivitis.
10071 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and VEA service for the clinical onset of conjunctivitis.
10072 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and operational service for the clinical onset of conjunctivitis.
or
10073 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and eligible service for the clinical onset of conjunctivitis.
or
the clinical onset of conjunctivitis of side and site of the body occurred after the end of the veteran's last period of VEA service. the veteran's conjunctivitis of side and site of the body permanently worsened.22048 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and VEA service for the clinical worsening of conjunctivitis.
22049 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and operational service for the clinical worsening of conjunctivitis.
or
22050 — the veteran has established the causal connection between the long term therapy with topically applied drugs or solutions and eligible service for the clinical worsening of conjunctivitis.
Clinical onset and operational service [10072]
the veteran received long term therapy with topically applied drugs or solutions to side and site of the body for treatment of the identified illness or injury within the 180 days immediately before the clinical onset of the condition under consideration.10074 — the identified illness or injury, for which the long term therapy with topically applied drugs or solutions to side and site of the body was given, is causally related to operational service.
Clinical onset and eligible service [10073]
the veteran received long term therapy with topically applied drugs or solutions to side and site of the body for treatment of the identified illness or injury within the 180 days immediately before the clinical onset of the condition under consideration.10075 — the identified illness or injury, for which the long term therapy with topically applied drugs or solutions to side and site of the body was given, is causally related to eligible service.
Clinical worsening and operational service [22049]
the veteran received long term therapy with topically applied drugs or solutions to side and site of the body for treatment of the identified illness or injury within the 180 days immediately before the clinical worsening of conjunctivitis of side and site of the body.10074 — the identified illness or injury, for which the long term therapy with topically applied drugs or solutions to side and site of the body was given, is causally related to operational service.
the clinical onset of conjunctivitis of side and site of the body occurred prior to that part of operational service to which the identified illness or injury, for which long term therapy with topically applied drugs or solutions was given, is causally related.Clinical worsening and eligible service [22050]
the veteran received long term therapy with topically applied drugs or solutions to side and site of the body for treatment of the identified illness or injury within the 180 days immediately before the clinical worsening of conjunctivitis of side and site of the body.10075 — the identified illness or injury, for which the long term therapy with topically applied drugs or solutions to side and site of the body was given, is causally related to eligible service.
the clinical onset of conjunctivitis of side and site of the body occurred prior to that part of eligible service to which the identified illness or injury, for which long term therapy with topically applied drugs or solutions was given, is causally related.